| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Merck & Co., Inc. (MRK) has 26 insiders with recent SEC Form 4 filings, including 0 buys and 5 sells. MRK is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 456.9K | $52.71M | - | |
| VP | 197.9K | $22.82M | - | |
| Dir | 110.9K | $12.79M | - | |
| Pres | 96.8K | $11.16M | - | |
| CFO | 94.2K | $10.87M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2015 | Deese Willie A | Exe V-p &Pres. Mmd | Sale+OE | 135,864 | $58.56 | $7,956,372.46 | -56.1% | |
| Feb 9, 2015 | Wendell Peter C | Director | Sale+OE | 5,000 | $58.76 | $293,797.00 | -83.3% | |
| Jan 15, 2015 | Schechter Adam H | EVP &Pres-global Human Health | Sale+OE | 74,200 | $62.48 | $4,636,223.76 | -100% | |
| Jan 9, 2015 | Frazier Kenneth C | Chairman, President &CEO | Sale+OE | 8,840 | $62.47 | $552,266.62 | -2.5% | |
| Oct 4, 2011 | Weeks Wendell P62 | Director | Sell | 100 | $31.35 | $3,135.00 | -100% |